A systematic review and meta-analysis evaluate treatment-emergent adverse events associated with trastuzumab deruxtecan in ...

Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa (DNL310) to address full disease spectrumLaunch readiness ...

The results paid off. In 11 months, I lost 100 pounds—all without ever stepping foot in a gym! I maintained that weight loss ...

Under terms announced December, Cencora acquired shares in OneOncology from TPG and other shareholders for approximately $3.6 ...

As the management landscape of primary biliary cholangitis (PBC) changes, new second-line options offer effective ...

Sleep lowers blood pressure, aiding heart health. It boosts the production of antibodies, supporting the immune system. It ...

Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology -HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals ...

Is your digestive system a constant source of trouble and pain? Here's what all those nagging symptoms can mean—and how to manage them.

Pfizer Balances COVID Drag With Pipeline Momentum in Latest Earnings Call The overall tone of Pfizer Inc.’s latest earnings call was cautiously optimistic, with management emphasizing underlying ...

Scientists have been researching whether or not antibodies from COVID-19 patients might help those infected with the virus, ...

Thank you, and welcome to everybody joining us today. Alongside this, we're continuing to make excellent progress in R&D, strengthening our late-stage portfolio and already securing four FDA approvals ...